Powered by OpenAIRE graph
Found an issue? Give us feedback
image/svg+xml art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos Open Access logo, converted into svg, designed by PLoS. This version with transparent background. http://commons.wikimedia.org/wiki/File:Open_Access_logo_PLoS_white.svg art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos http://www.plos.org/ ZENODOarrow_drop_down
image/svg+xml art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos Open Access logo, converted into svg, designed by PLoS. This version with transparent background. http://commons.wikimedia.org/wiki/File:Open_Access_logo_PLoS_white.svg art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos http://www.plos.org/
ZENODO
Dataset
Data sources: ZENODO
Zenodo
Claim

FDA Submission-to-Approval Review Times for First-in-Molecule Oncology Drugs, 2000 to 2025: Analytic Dataset

Research datakeyboard_double_arrow_right Dataset Under curationPublisher:Zenodo
Authors: Kay, Saman;

doi: 10.5281/zenodo.20548955

FDA Submission-to-Approval Review Times for First-in-Molecule Oncology Drugs, 2000 to 2025: Analytic Dataset

No summary information available
Powered by OpenAIRE graph
Found an issue? Give us feedback